Literature DB >> 17332126

Proximal femoral allograft treatment of Vancouver type-B3 periprosthetic femoral fractures after total hip arthroplasty. Surgical technique.

Catherine F Kellett1, Petros J Boscainos, Anthony C Maury, Ari Pressman, Barry Cayen, Paul Zalzal, David Backstein, Allan Gross.   

Abstract

BACKGROUND: Periprosthetic femoral fractures following total hip arthroplasty are becoming more prevalent. When a fracture occurs in a femur with substantial proximal bone deficiency, the surgical options for revision are limited. One option includes the use of a proximal femoral allograft.
METHODS: We retrospectively assessed the results and complications of the use of a proximal femoral allograft to treat twenty-five Vancouver type-B3 periprosthetic fractures in twenty-four patients. The mean duration of follow-up was 5.1 years. Clinical results were graded with use of the Harris hip score. Radiographs were assessed for evidence of trochanteric union, host-allograft union, allograft resorption, and component loosening or fracture. Failure of the procedure was defined as the need for revision surgery requiring graft removal.
RESULTS: The mean postoperative Harris hip score was 70.8. At the time of the final follow-up, twenty-one of the twenty-four patients reported no or mild pain and twenty-three patients were able to walk; fifteen required a walking aid. The greater trochanter united in seventeen of the twenty-five hips (68%), and osseous union of the allograft to the host femur occurred in twenty hips (80%). There was mild graft resorption in four hips and moderate graft resorption in two. Four (16%) of the twenty-five hips required repeat revision.
CONCLUSIONS: The use of a proximal femoral allograft for the treatment of a Vancouver type-B3 periprosthetic femoral fracture can provide a satisfactory result in terms of pain relief and function at five years.

Entities:  

Mesh:

Year:  2007        PMID: 17332126     DOI: 10.2106/JBJS.F.01047

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  7 in total

1.  Polyaxial Locked Implants in the Treatment of Type Vancouver B1 Periprosthetic Fractures of the Femur: Retrospective Clinical Examination in 58 Cases with Review of the Literature.

Authors:  Jan Meiners; Maximilian Faschingbauer; Christine Voigt; Christian Jürgens; Arndt P Schulz
Journal:  Eur J Trauma Emerg Surg       Date:  2009-07-10       Impact factor: 3.693

2.  Revision of the deficient proximal femur with a proximal femoral allograft.

Authors:  Oleg Safir; Catherine F Kellett; Michael Flint; David Backstein; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2008-10-30       Impact factor: 4.176

3.  Total hip arthroplasty in patients with Down's syndrome.

Authors:  Yona Kosashvili; Drew Taylor; David Backstein; Oleg Safir; Boaz Liberman; Dror Lakstein; Allan Gross
Journal:  Int Orthop       Date:  2010-05-05       Impact factor: 3.075

4.  Management of late periprosthetic femur fractures: a retrospective cohort of 72 patients.

Authors:  Cibu Mukundan; Faizal Rayan; Ehab Kheir; D Macdonald
Journal:  Int Orthop       Date:  2009-06-10       Impact factor: 3.075

5.  Vancouver type B2 and B3 periprosthetic fractures treated with revision total hip arthroplasty.

Authors:  Tomas Amenabar; Wael A Rahman; Vineet V Avhad; Ramiro Vera; Allan E Gross; Paul R Kuzyk
Journal:  Int Orthop       Date:  2015-08-25       Impact factor: 3.075

6.  Autograft-prosthesis composite use for a Vancouver type B1 periprosthetic femur fracture with pelvic acetabular component migration after bipolar hemiarthroplasty: A case report.

Authors:  Hironori Ochi; Tomonori Baba; Hiroki Tanabe; Yu Ozaki; Taiji Watari; Yasuhiro Homma; Mikio Matsumoto; Kazuo Kaneko
Journal:  Trauma Case Rep       Date:  2019-06-21

7.  Proximal femoral replacement for non-neoplastic conditions: a systematic review on current outcomes.

Authors:  Alberto Di Martino; Davide Pederiva; Barbara Bordini; Gabriele Di Carlo; Alessandro Panciera; Giuseppe Geraci; Niccolò Stefanini; Cesare Faldini
Journal:  J Orthop Traumatol       Date:  2022-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.